MRK

Merck & Co.

Health Care

Pharmaceuticals

Kenilworth, New Jersey

Balance Sheet 36 Accounts • 5 Years

Account	2024	2023	2022	2021	2020
end	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31
Assets - CashAndCashEquivalents	$13.2B	$6.8B	$12.7B	$8.1B	$8.1B
Assets - MarketableSecuritiesCurrent	$447.0M	$252.0M	$498.0M	$86.0M	$0
Assets - AccountsReceivable	$10.3B	$10.3B	$9.4B	$9.2B	$6.8B
Assets - Inventories	$6.1B	$6.4B	$5.9B	$6.0B	$5.6B
Assets - PrepaidExpensesAndOtherCurrentAssets	$8.7B	$8.4B	$7.2B	$7.0B	$4.7B
Assets - TotalCurrentAssets	$38.8B	$32.2B	$35.7B	$30.3B	$27.8B
Assets - Property,PlantAndEquipment	$23.8B	$23.1B	$21.4B	$19.3B	$17.0B
Assets - Goodwill	$21.7B	$21.2B	$21.2B	$21.3B	$18.9B
Assets - IntangibleAssets(net,ExcludingGoodwill)	$16.4B	$18.0B	$20.3B	$22.9B	$14.1B
Assets - OperatingLeaseAssets	$1.4B	$1.4B	$1.3B	$1.6B	$1.7B
Assets - MarketableSecuritiesNoncurrent	$463.0M	$252.0M	$1.0B	$370.0M	$785.0M
Assets - DeferredTaxAssets	$5.3B	$4.1B	$3.0B	$2.3B	$2.4B
Assets - OtherNoncurrentAssets	$16.0B	$12.0B	$9.5B	$2.2B	$2.1B
Assets - TotalAssets	$117.1B	$106.7B	$109.2B	$105.7B	$91.6B
Liabilities - AccountsPayable	$4.1B	$3.9B	$4.3B	$4.6B	$4.3B
Liabilities - AccruedLiabilities	$6.0B	$4.6B	$3.9B	$3.0B	$3.3B
Liabilities - ShortTermDebtAndCurrentPortionOfLongTermDebt	$2.6B	$1.4B	$1.9B	$2.4B	$6.4B
Liabilities - OperatingLeaseLiabilitiesCurrent	$282.0M	$285.0M	$281.0M	$304.0M	$291.0M
Liabilities - ContingentConsiderationLiabilityCurrent	$148.0M	$128.0M	$122.0M	$151.0M	$148.0M
Liabilities - OtherCurrentLiabilities	$15.7B	$15.8B	$14.2B	$13.9B	$12.2B
Liabilities - TotalCurrentLiabilities	$28.4B	$25.7B	$24.2B	$23.9B	$27.3B
Liabilities - LongTermDebt	$34.5B	$33.7B	$28.7B	$30.7B	$25.4B
Liabilities - OperatingLeaseLiabilitiesNoncurrent	$877.0M	$928.0M	$1.0B	$1.2B	$1.3B
Liabilities - DeferredTaxLiabilitiesNoncurrent	$1.4B	$871.0M	$1.8B	$3.4B	$1.0B
Liabilities - ContingentConsiderationLiabilityNoncurrent	$193.0M	$354.0M	$456.0M	$777.0M	$841.0M
Liabilities - OtherNoncurrentLiabilities	$6.5B	$8.8B	$8.3B	$9.4B	$12.3B
Equity - PreferredStock	$20.0M	$20.0M	$20.0M	$20.0M	$20.0M
Equity - CommonStock	$1.8B	$1.8B	$1.8B	$1.8B	$1.8B
Equity - AdditionalPaidInCapital	$44.7B	$44.5B	$44.4B	$44.2B	$39.6B
Equity - RetainedEarnings(deficit)	$63.1B	$53.9B	$61.1B	$53.7B	$47.4B
Equity - TreasuryStock	$1.3B	$1.3B	—	$57.1B	$56.8B
Equity - AccumulatedOtherComprehensiveIncome(loss)	$-4.9B	$-5.2B	$-4.8B	$-4.4B	$-6.6B
Equity - NoncontrollingInterest(permanentEquity)	$59.0M	$54.0M	$67.0M	$73.0M	$87.0M
Equity - TotalStockholdersEquity	$46.3B	$37.6B	$46.0B	$38.2B	$25.3B
Equity - TotalLiabilitiesAndStockholdersEquity	$117.1B	$106.7B	$109.2B	$105.7B	$91.6B

Income Statement 22 Accounts • 5 Years

Account	2024	2023	2022	2021	2020
end	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31
IncomeStatement - Revenues - NetProductSales/Revenues	$64.2B	$60.1B	$59.3B	$48.7B	$41.5B
IncomeStatement - CostsAndExpenses - CostOfGoodsSold	$15.2B	$16.1B	$17.4B	$13.6B	$13.6B
IncomeStatement - CostsAndExpenses - ResearchAndDevelopmentExpense	$17.9B	$30.5B	$13.5B	$12.2B	$13.4B
IncomeStatement - CostsAndExpenses - Selling,GeneralAndAdministrative(andMarketing)	$10.8B	$10.5B	$10.0B	$9.6B	$9.0B
IncomeStatement - CostsAndExpenses - AmortizationOfIntangibleAssets(operating)	$2.4B	$2.0B	$2.1B	$1.6B	$1.8B
IncomeStatement - CostsAndExpenses - Depreciation(operating)	$2.1B	$1.8B	$1.8B	$1.6B	$1.7B
IncomeStatement - CostsAndExpenses - RestructuringAndImpairmentCharges	$309.0M	$599.0M	$337.0M	$661.0M	$575.0M
IncomeStatement - OtherIncomeExpense - InterestIncome	$415.0M	$365.0M	$157.0M	$36.0M	$59.0M
IncomeStatement - OtherIncomeExpense - Gain(loss)OnInvestments/EquityMethod	$14.0M	$340.0M	$-1.4B	$1.9B	$1.3B
IncomeStatement - OtherIncomeExpense - OtherNonoperatingIncome(expense)	$24.0M	$-466.0M	$-1.5B	$1.3B	$890.0M
IncomeStatement - OtherIncomeExpense - Income(loss)FromContinuingOperationsBeforeIncomeTaxes	$19.9B	$1.9B	$16.4B	$13.9B	$5.9B
IncomeStatement - IncomeTax - IncomeTaxExpense(benefit)	$2.8B	$1.5B	$1.9B	$1.5B	$1.3B
IncomeStatement - IncomeTax - EffectiveTaxRate(continuingOperations)	$0	$1	$0	$0	$0
IncomeStatement - NetIncomeAndEps - NetIncome(loss)	$17.1B	$365.0M	$14.5B	$13.0B	$7.1B
IncomeStatement - NetIncomeAndEps - NetIncome(loss)AttributableToNoncontrollingInterest	$16.0M	$12.0M	$7.0M	$16.0M	$15.0M
IncomeStatement - NetIncomeAndEps - NetIncome(loss)AttributableToCompany	$17.1B	$365.0M	$14.5B	$13.0B	$7.1B
IncomeStatement - NetIncomeAndEps - BasicEarningsPerShare	$7	$0	$6	$5	$3
IncomeStatement - NetIncomeAndEps - DilutedEarningsPerShare	$7	$0	$6	$5	$3
IncomeStatement - NetIncomeAndEps - WeightedAverageSharesOutstandingBasic	$2.5B	$2.5B	$2.5B	$2.5B	$2.5B
IncomeStatement - NetIncomeAndEps - WeightedAverageSharesOutstandingDiluted	$2.5B	$2.5B	$2.5B	$2.5B	$2.5B
IncomeStatement - NetIncomeAndEps - ComprehensiveIncome(loss)	$17.3B	$-28.0M	$14.2B	$14.8B	$6.6B

Cash Flow Statement 20 Accounts • 5 Years

Account	2024	2023	2022	2021	2020
end	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31
CashFlow - OperatingActivities - NetIncome	$17.1B	$365.0M	$14.5B	$13.0B	$7.1B
CashFlow - OperatingActivities - DepreciationAndAmortization	$2.1B	$1.8B	$1.8B	$1.6B	$1.7B
CashFlow - OperatingActivities - ShareBasedCompensation	$761.0M	$645.0M	$541.0M	$479.0M	$441.0M
CashFlow - OperatingActivities - DeferredIncomeTaxes	$-1.2B	$-1.9B	$-1.6B	$187.0M	$-566.0M
CashFlow - OperatingActivities - ChangesInOperatingAssetsAndLiabilities	$1.4B	$2.3B	$1.5B	$1.8B	$2.4B
CashFlow - OperatingActivities - NetCashFromOperatingActivities(continuingOperations)	$21.5B	$13.0B	$19.1B	—	$10.3B
CashFlow - InvestingActivities - AcquisitionsOfBusinesses,NetOfCash	$746.0M	$0	$0	$179.0M	$1.4B
CashFlow - InvestingActivities - OtherInvestingActivities	$127.0M	$36.0M	$89.0M	$91.0M	$-125.0M
CashFlow - InvestingActivities - NetCashFromInvestingActivities(continuingOperations)	$-7.7B	$-14.1B	$-5.0B	—	$-9.4B
CashFlow - FinancingActivities - RepaymentsOfDebt	$1.3B	$1.8B	$2.3B	$2.3B	$2.0B
CashFlow - FinancingActivities - PaymentsForRepurchaseOfCommonStock	$1.3B	$1.3B	$0	$840.0M	$1.3B
CashFlow - FinancingActivities - PaymentOfDividends	$7.9B	$7.6B	$7.1B	$6.7B	$6.3B
CashFlow - FinancingActivities - ProceedsFromStockOptionsExercised/SharePlans	$177.0M	$125.0M	$384.0M	$202.0M	$89.0M
CashFlow - FinancingActivities - OtherFinancingActivities	$-372.0M	$-328.0M	$-240.0M	$-286.0M	$-436.0M
CashFlow - FinancingActivities - NetCashFromFinancingActivities(continuingOperations)	$-7.0B	$-4.8B	$-9.1B	—	$-2.8B
CashFlow - CashReconciliationAndSupplemental - EffectOfExchangeRateChangesOnCash	$-293.0M	$23.0M	$-410.0M	$-133.0M	$253.0M
CashFlow - CashReconciliationAndSupplemental - NetChangeInCash	$6.4B	$-5.9B	$4.6B	$14.0M	$-1.8B
CashFlow - CashReconciliationAndSupplemental - IncomeTaxesPaid	$3.9B	$4.3B	$3.2B	$2.4B	$2.7B
CashFlow - CashReconciliationAndSupplemental - RightOfUseAssetsObtainedForLeases(nonCash)	$47.0M	$122.0M	$57.0M	$117.0M	$473.0M

Merck & Co.

Balance Sheet 36 Accounts • 5 Years

Income Statement 22 Accounts • 5 Years

Cash Flow Statement 20 Accounts • 5 Years

Stock Market Data (1 Year) Live Yahoo Finance Data

Recent Price History